The Enterprise Value as of June 2026 (TTM) for Achilles Therapeutics plc (ACHL) is -66096000.00

According to Achilles Therapeutics plc’s latest financial reports and current stock price. The company's current Enterprise Value is -66096000.00. This represents a change of 6.42% compared to the average of -62108657.65 of the last 4 quarters.

Achilles Therapeutics plc (ACHL) Historical Enterprise Value (quarterly & annually)

How has ACHL Enterprise Value performed in the past?

The mean historical Enterprise Value of Achilles Therapeutics plc over the last ten years is 15.25M. The current -66096000.00 Enterprise Value has changed -43453.21% with respect to the historical average. Over the past ten years (40 quarters), ACHL's Enterprise Value was at its highest in in the December 2020 quarter at 510.42M. The Enterprise Value was at its lowest in in the December 2022 quarter at -129194981.00.

Achilles Therapeutics plc (ACHL) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Achilles Therapeutics plc Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Achilles Therapeutics plc (ACHL) Average Enterprise Value

How has ACHL Enterprise Value performed in the past?

The current Enterprise Value of Achilles Therapeutics plc (ACHL) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Achilles Therapeutics plc (ACHL) Enterprise Value vs. Peers

How is ACHL’s Enterprise Value compared to its peers?

Achilles Therapeutics plc’s Enterprise Value is greater than Reneo Pharmaceuticals, Inc. (-130856584.00), less than TCR2 Therapeutics Inc. (79.12M), less than Heat Biologics, Inc. (18.12T), less than Surface Oncology, Inc. (70.21M), less than Kronos Bio, Inc. (-13835104.00), less than Sigilon Therapeutics, Inc. (42.21M), less than Quince Therapeutics, Inc. (-12558018.00), less than AlloVir, Inc. (47.97M), less than Rein Therapeutics Inc. (27.26M), less than The Valens Company Inc. (-670000.00),

Build a custom stock screener for Achilles Therapeutics plc (ACHL) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Achilles Therapeutics plc using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Achilles Therapeutics plc (ACHL) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Achilles Therapeutics plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.